Sat.Jun 08, 2024 - Fri.Jun 14, 2024

article thumbnail

Pharmacists Can Help Alleviate Men’s Mental Health Crisis

Drug Topics

Patrick Alonso, PharmD, CPh, discusses how pharmacists can support men dealing with mental health issues and lifestyle changes he recommends to male patients to improve overall health.

503
503
article thumbnail

Behind Big Pharma’s layoffs — is there an end in sight?

PharmaVoice

A slew of major companies, including BMS, have announced cost-cutting measures in recent months. What will it take to turn the tide?

278
278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Tralokinumab-ldrm Autoinjector for Adults With Atopic Dermatitis

Pharmacy Times

The autoinjector will provide another option for adults in addition to the prefilled syringe that is currently available.

FDA 156
article thumbnail

Global health leader critiques ‘ineptitude’ of U.S. response to bird flu outbreak among cows

STAT

LONDON — Seth Berkley, a longtime and widely respected global health leader , said Thursday that it has been “shocking to watch the ineptitude” of the U.S. response to the avian influenza outbreak among dairy cattle , adding his voice to a chorus of critics. In a presentation in London about vaccine development, Berkley, the former CEO of Gavi, the Vaccine Alliance, raised the issue of H5N1 bird flu when discussing whether the world was ready for another pandemic following i

Vaccines 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Cannabis to Treat Cancer: Younger Populations Reluctant to Disclose as Overall Use Becomes More Accepted

Drug Topics

Researchers addressed the use of cannabis to treat cancer symptoms in rural and urban areas, as well as patients’ comfortability discussing it with their providers.

548
548
article thumbnail

Behind the powerful computations, AI’s role in pharma is still beset by challenges

PharmaVoice

Small biotechs are saving time and money leveraging AI to develop new drugs, but incomplete data and disease complexity remain hurdles for the space.

237
237

More Trending

article thumbnail

In dribs and drabs, USDA reports suggest containing bird flu outbreak in dairy cows will be challenging

STAT

The U.S. Department of Agriculture released two reports Thursday that lay out what has been learned about how H5N1 bird flu is moving among dairy cow herds in the United States. The reports do not shed much new light on the situation. Instead, they sum up what is known: that the outbreak was probably the result of a single “spillover” of the virus from wild birds into a dairy herd, likely late last year, and that movement of cows, farmworkers, and shared equipment appears to be res

145
145
article thumbnail

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Drug Topics

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

528
528
article thumbnail

Pfizer’s Paxlovid flunks long COVID study as researchers uncover the condition’s deep toll

PharmaVoice

While researchers gain ground understanding long COVID’s impact, viable treatments could still be a long way off.

147
147
article thumbnail

Implications for Pharmacies Navigating Shared Clinical Decision-Making in Vaccination

Pharmacy Times

The SCDM model demands more than the traditional roles assigned to pharmacists, requiring an enhanced level of patient engagement, medical knowledge, and legal authority to implement effectively

Vaccines 149
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Opinion: The J&J lawsuit should be a wakeup call to the PBM industry — and to companies everywhere

STAT

The ongoing legal dispute involving Johnson & Johnson has again thrust the topic of pharmacy benefit managers (PBMs) into the spotlight. Ann Lewandowski, a J&J employee, sued the company for overpaying for its employees’ prescription drugs through its PBM, Express Scripts, claiming that these overpayments resulted in higher health insurance premiums and out-of-pocket drug costs for employees.

Insurance 145
article thumbnail

FDA, DOJ Launch Multi-Agency Task Force to Address Illegal E-Cigarettes

Drug Topics

The new task force highlights a stronger government focus on curbing the risks of e-cigarettes for young people, especially after sustained calls for stricter action on the public health issue by lawmakers and the public.

FDA 529
article thumbnail

As Big Pharma places bigger bets on ADCs, here’s where the field is headed next

PharmaVoice

With more drugmakers getting into the antibody-drug conjugate game, emerging innovations signal a bright future for the technology.

147
147
article thumbnail

The Role of Medicinal Plants in Modern Pharmacy

Pharmacy Times

Researchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Michigan stands out for its aggressive bird flu response. Will other states follow its lead?

STAT

For weeks now, as the H5N1 bird flu has been spreading into dairy cattle herds in more and more places, one state continues to lead the pack. With reports of infections in 25 herds, Michigan currently accounts for about one-third of the country’s confirmed cases in livestock. And of the three people known to have contracted the H5N1 virus from sick cows since the outbreak began, two of them are farmworkers in Michigan, including one who experienced respiratory symptoms.

145
145
article thumbnail

After DOJ Indictment, CDC Urges Caution Around ADHD Medications

Drug Topics

The CDC released an alert encouraging pharmacists and providers to counsel patients around the harms of illegal stimulant medications.

503
503
article thumbnail

Modifier gene therapy – clinical development and manufacturing considerations

European Pharmaceutical Review

Tell us about Ocugen’s lead programme, OCU400. What’s the latest and what’s next? OCU400 is a modifier gene therapy aimed at treating retinitis pigmentosa and Leber congenital amaurosis (LCA). In April 2024, Ocugen received US Food and Drug Administration (FDA) clearance to initiate the Phase III liMeliGhT clinical trial for OCU400 for retinitis pigmentosa.

article thumbnail

2024 shaping up to be a big year for healthcare AI companies. But some investors remain cautious

Fierce Healthcare

AI deal activity is dominating healthcare investment with one in four dollars invested in healthcare going toward companies leveraging AI, according to a new report. | So far, in 2024, $2.8 billion has already been invested in AI healthcare companies, with SVB projecting the sector to see $11.

139
139
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy

STAT

Early in her pregnancy in 2015, Nicole Hashemi wanted to know how much caffeine was safe for her to consume. “I was actually advised not to drink a lot of caffeine,” Hashemi, an associate professor of mechanical engineering at Iowa State University, told STAT. The American College of Obstetrics and Gynecologists, for instance, advises that pregnant people consume no more than 200 milligrams per day  to reduce the risk of miscarriage or preterm birth.

145
145
article thumbnail

Men Should Prioritize Self-Care, Reduce Substance Use to Improve Mental Health

Drug Topics

Patrick Alonso, PharmD, CPh, provides some tips for men looking to improve their overall mental health.

503
503
article thumbnail

Navigating the Deluge of Clinical Literature During and After COVID-19: Insights From ASHP Pharmacy Futures 2024

Pharmacy Times

Speakers at American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2024 discuss the significant increase in published clinical literature during and after the COVID-19 pandemic, and the evolving role and reliability of AI tools such as ChatGPT in providing accurate medical information.

139
139
article thumbnail

Microsoft rolls out program to help rural hospitals defend against cyberattacks

Fierce Healthcare

Microsoft will offer nonprofit pricing and discounts for its security products optimized for smaller organizations, providing up to a 75% discount.

Hospitals 135
article thumbnail

Opinion: Getting farmworkers to use PPE is hard, but it’s the best way to stop an H5N1 bird flu epidemic

STAT

Although a third U.S. dairy worker has been confirmed to be infected with the H5N1 bird flu, many dairy farms are still unwilling to use even freely offered personal protective equipment (PPE). This is cause for alarm. Working with a pathogen assigned a biosafety level of 3 — meaning it “can cause serious or potentially lethal disease through respiratory transmission” — with at best BSL 2 level protections is playing with fire.

145
145
article thumbnail

Vitamin D Testing: Uncovering Potential Inaccuracies

Drug Topics

CDC researchers reported on the improvements and inaccuracies of assays within the Vitamin D Standardization-Certification Program.

486
486
article thumbnail

Novel Treatments Could Turn the Tide for Alzheimer Disease

Pharmacy Times

Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.

132
132
article thumbnail

Europe taps CSL Seqirus to produce bird flu vaccines for pandemic preparedness efforts

Fierce Pharma

Right after signing on to help with bird flu pandemic preparedness efforts in the U.S., CSL Seqirus has agreed to do the same in Europe through a vaccine supply pact. | The vaccine maker will deliver 665,000 doses of its avian flu-matched pre-pandemic vaccine. Under a 4-year contract, authorities can purchase up to 40 million doses.

Vaccines 131
article thumbnail

Four Tops singer’s lawsuit says he visited ER for chest pain, ended up in straightjacket

STAT

When Alexander Morris, a member of the Motown group The Four Tops , visited a Detroit-area Ascension hospital with chest pain and trouble breathing, he said the staff assumed he was mentally ill after he told them he was a famous singer. Instead of treating Morris, a white security guard told him to “sit his Black ass down” and he was placed in a straightjacket, Morris claims in a new lawsuit.

Hospitals 145
article thumbnail

Stopping the Syndemic: Pharmacy at the Intersection of HIV and Injection Drug Use

Drug Topics

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

441
441
article thumbnail

Regenxbio CEO to step down after 15 years

PharmaVoice

Kenneth Mills will become chair of the gene therapy developer's board while Curran Simpson, the current chief operating officer, will take his place as company head.

130
130
article thumbnail

Report: Medicare Advantage quality ratings to get new calculations

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) appears poised to rework Medicare Advantage (MA) quality ratings for this year, The Wall Street Journal

128
128
article thumbnail

Opinion: Certificate of need laws con rural patients out of health care

STAT

News watchers around the U.S. have likely seen the warnings: without certificate of need (CON) laws, hospitals will be forced to close their doors when for-profit organizations open and cherry pick commercially insured patients, leaving those in rural areas without care. The reality is that even with certificate of need laws in place, rural patients are already without care.

Hospitals 145
article thumbnail

Moderna: Combination COVID-19–Flu Vaccine Trial Meets Primary Endpoints

Drug Topics

The vaccine, mRNA-1083, elicited noninferior responses vs individual COVID-19 and flu vaccinations.

Vaccines 385
article thumbnail

Despite detractors, Lilly’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now

PharmaVoice

Lilly is the latest to approach the coveted Alzheimer’s approval, but a slate of drugmakers are lining up clinical trials in amyloid and tau to take a shot at improving patient outcomes.

130
130